Q4 2019 Atara Biotherapeutics Inc Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the Atara Biotherapeutics Q4 and Full Year 2019 Financial Results Conference Call. (Operator Instructions).
I'd now like to turn the conference over to your host, Dr. John Craighead, Vice President of Investor Relations and Corporate Communications of Atara Biotherapeutics. Please go ahead.
Thank you, operator. Good morning everyone, and welcome to Atara's fourth quarter and full year 2019 conference call. On today's call, we will provide an update of our clinical, operational and strategic progress, as well as a review of our upcoming milestones and key objectives for 2020.
Earlier this morning, we issued a press release providing an overview of the company's fourth quarter and full year 2019 financial results. This press release and an updated investor presentation are available in the Investor & Media section at atarabio.com.
Joining me on today's call are Dr. Pascal Touchon, President and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |